FineMark National Bank & Trust’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,146
Closed -$244K 1519
2014
Q4
$244K Buy
1,146
+47
+4% +$9.35K 0.04% 317
2014
Q3
$195K Sell
1,099
-169
-13% -$28.1K 0.03% 345
2014
Q2
$214K Buy
1,268
+144
+13% +$22.4K 0.04% 322
2014
Q1
$139K Sell
1,124
-184
-14% -$22.4K 0.03% 381
2013
Q4
$146K Buy
1,308
+13
+1% +$1.24K 0.03% 356
2013
Q3
$117K Buy
1,295
+466
+56% +$41.8K 0.03% 392
2013
Q2
$70K Buy
+829
New +$86K 0.02% 473

Other funds holding AGN

FineMark National Bank & Trust's AGN Position: Q1 2015 in Review

FineMark National Bank & Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,146 shares — an estimated $244K sold.

FineMark National Bank & Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $244K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • FineMark National Bank & Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 1,146 Allergan Inc shares in Q1 2015, an estimated $244K.
  • FineMark National Bank & Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • FineMark National Bank & Trust's Allergan Inc position peaked at $244K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on FineMark National Bank & Trust's 13F filing for Q1 2015, filed 13 May 2015.